Correlation Between NewAmsterdam Pharma and UroGen Pharma
Can any of the company-specific risk be diversified away by investing in both NewAmsterdam Pharma and UroGen Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining NewAmsterdam Pharma and UroGen Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between NewAmsterdam Pharma and UroGen Pharma, you can compare the effects of market volatilities on NewAmsterdam Pharma and UroGen Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in NewAmsterdam Pharma with a short position of UroGen Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of NewAmsterdam Pharma and UroGen Pharma.
Diversification Opportunities for NewAmsterdam Pharma and UroGen Pharma
-0.67 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between NewAmsterdam and UroGen is -0.67. Overlapping area represents the amount of risk that can be diversified away by holding NewAmsterdam Pharma and UroGen Pharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on UroGen Pharma and NewAmsterdam Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on NewAmsterdam Pharma are associated (or correlated) with UroGen Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of UroGen Pharma has no effect on the direction of NewAmsterdam Pharma i.e., NewAmsterdam Pharma and UroGen Pharma go up and down completely randomly.
Pair Corralation between NewAmsterdam Pharma and UroGen Pharma
Given the investment horizon of 90 days NewAmsterdam Pharma is expected to generate 1.74 times more return on investment than UroGen Pharma. However, NewAmsterdam Pharma is 1.74 times more volatile than UroGen Pharma. It trades about 0.1 of its potential returns per unit of risk. UroGen Pharma is currently generating about 0.06 per unit of risk. If you would invest 1,897 in NewAmsterdam Pharma on August 30, 2024 and sell it today you would earn a total of 183.00 from holding NewAmsterdam Pharma or generate 9.65% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Weak |
Accuracy | 100.0% |
Values | Daily Returns |
NewAmsterdam Pharma vs. UroGen Pharma
Performance |
Timeline |
NewAmsterdam Pharma |
UroGen Pharma |
NewAmsterdam Pharma and UroGen Pharma Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with NewAmsterdam Pharma and UroGen Pharma
The main advantage of trading using opposite NewAmsterdam Pharma and UroGen Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if NewAmsterdam Pharma position performs unexpectedly, UroGen Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in UroGen Pharma will offset losses from the drop in UroGen Pharma's long position.NewAmsterdam Pharma vs. Ikena Oncology | NewAmsterdam Pharma vs. Eliem Therapeutics | NewAmsterdam Pharma vs. HCW Biologics | NewAmsterdam Pharma vs. RenovoRx |
UroGen Pharma vs. Eliem Therapeutics | UroGen Pharma vs. Inhibrx | UroGen Pharma vs. Celcuity LLC | UroGen Pharma vs. Enliven Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.
Other Complementary Tools
Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
Insider Screener Find insiders across different sectors to evaluate their impact on performance |